Clinical Trial Update: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects [Phase 3]

View source ↗

Summary

Phase 3 study assessing the pharmacokinetics and antiviral activity of dolutegravir in the central nervous system in ART-naive HIV-1-infected subjects; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dolutegravir (dolutegravir)
• Tivicay (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED | Results posted: 2013-11-25